WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Advertisement
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jhamandas, K. H.
Right arrow Articles by Yaksh, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jhamandas, K. H.
Right arrow Articles by Yaksh, T. L.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 16, 2758-2766, Copyright © 1996 by Society for Neuroscience


ARTICLE

Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine

KH Jhamandas, M Marsala, T Ibuki and TL Yaksh
Department of Anesthesia, University of California at San Diego, Ja Jolla 92093-0818, USA.

Glutamate receptors are implicated in the genesis of opioid tolerance and dependence. Factors governing release of amino acids in systems chronically exposed to opiates, however, remain undefined. Using rats, each prepared with a spinal loop dialysis catheter and with a chronic lumbar intrathecal infusion catheter connected to a subcutaneous minipump, the release of amino acids before and during antagonist- precipitated withdrawal in unanesthetized rats was examined. Spinal infusion of morphine (20 nmol/micro l/hr) for 4 d had little effect on resting release of amino acids. In morphine-infused, but not saline- infused, rats naloxone (2 mg/kg, i.p.) evoked an immediate increase in the release of L-glutamate (299 +/- 143%) and taurine (306 +/- 113%) but not other amino acids. The magnitude and time course of the release of these amino acids significantly correlated with behavioral indices of withdrawal intensity. Acute intrathecal pretreatment immediately before naloxone with clonidine (20 microg; alpha2 agonist), MK-801 (3 microg; noncompetitive NMDA antagonist), or aminophosphonopentanoic acid (AP-5; 3 microg; competitive NMDA antagonist) suppressed naloxone- induced increases in spinal L-glutamate and taurine release and behavioral signs of withdrawal in spinal morphine-infused rats. Results point to a correlated increase in spinal L-glutamate release, which contributes to genesis of the opioid withdrawal syndrome. Agents such as clonidine that suppress opioid withdrawal may owe their action to an inhibition of excitatory amino acid release. The effects of MK-801 and AP-5 suggest a glutamate-evoked glutamate release.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
G. Gu, I. Kondo, X.-Y. Hua, and T. L. Yaksh
Resting and Evoked Spinal Substance P Release during Chronic Intrathecal Morphine Infusion: Parallels with Tolerance and Dependence
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1362 - 1369.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. Petersson, M. Granmo, and J. Schouenborg
Properties of an Adult Spinal Sensorimotor Circuit Shaped Through Early Postnatal Experience
J Neurophysiol, July 1, 2004; 92(1): 280 - 288.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Koetzner, X.-Y. Hua, J. Lai, F. Porreca, and T. Yaksh
Nonopioid Actions of Intrathecal Dynorphin Evoke Spinal Excitatory Amino Acid and Prostaglandin E2 Release Mediated by Cyclooxygenase-1 and -2
J. Neurosci., February 11, 2004; 24(6): 1451 - 1458.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C.-R. Lin, L.-C. Yang, H.-L. You, C.-T. Lee, M.-H. Tai, P.-H. Tan, M.-W. Lin, and J.-T. Cheng
Antinociceptive Potentiation and Attenuation of Tolerance by Intrathecal Electric Stimulation in Rats
Anesth. Analg., June 1, 2003; 96(6): 1711 - 1716.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Mao, B. Sung, R.-R. Ji, and G. Lim
Chronic Morphine Induces Downregulation of Spinal Glutamate Transporters: Implications in Morphine Tolerance and Abnormal Pain Sensitivity
J. Neurosci., September 15, 2002; 22(18): 8312 - 8323.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Mao, B. Sung, R.-R. Ji, and G. Lim
Neuronal Apoptosis Associated with Morphine Tolerance: Evidence for an Opioid-Induced Neurotoxic Mechanism
J. Neurosci., September 1, 2002; 22(17): 7650 - 7661.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
C.-S. Wong, Y.-C. Chang, C.-C. Yeh, G.-S. Huang, and C.-H. Cherng
Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF: [La perte d'analgesie morphinique intrathecale chez les patients atteints de cancer terminal est associee a des niveaux eleves d'acides amines excitateurs dans le LCR]
Can J Anesth, June 1, 2002; 49(6): 561 - 565.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. A. Dunbar, I. G. Karamov, and H. Buerkle
The Effect of Spinal Ibuprofen on Opioid Withdrawal in the Rat
Anesth. Analg., August 1, 2000; 91(2): 417 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. A. Dunbar and I. J. Pulai
Repetitive Opioid Abstinence Causes Progressive Hyperalgesia Sensitive to N-Methyl-D-aspartate Receptor Blockade in the Rat
J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 678 - 686.
[Abstract] [Full Text]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-